Histogen to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Rhea-AI Summary

Histogen Inc. (NASDAQ: HSTO) has announced that its CEO, Richard W. Pascoe, will present at the H.C. Wainwright 23rd Annual Global Investment Conference on September 13, 2021. The presentation will be available on-demand starting at 7:00 AM ET. Histogen focuses on developing innovative restorative therapeutics that aim to stimulate the body's natural repair processes. Their technology includes cell-conditioned media and extracellular matrix materials aimed at treating various conditions such as joint cartilage and soft tissue repair.

SAN DIEGO, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function, today announced that Richard W. Pascoe, President and Chief Executive Officer of Histogen, will present at the H.C. Wainwright 23^rd Annual Global Investment Conference.

Presentation Details

The presentation will be available for on-demand listening beginning Monday, September 13, 2021 at 7:00 AM Eastern Time and can be accessed using the link https://journey.ct.events/view/c065249e-2ede-44de-ad16-38ecae89a28d.

About Histogen Inc.

Histogen Inc. is a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function. Histogen’s innovative technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells. Histogen’s proprietary, reproducible manufacturing process provides targeted solutions across a broad range of therapeutic indications, including joint cartilage regeneration, spinal disk repair, tendon, ligament and other soft tissue repair. For more information, please visit www.histogen.com.

CONTACT:

Susan A. Knudson
Executive Vice President & CFO
Histogen Inc.
ir@histogen.com

FAQ

When is Histogen's presentation at the H.C. Wainwright 23rd Annual Global Investment Conference?

Histogen's presentation will be available on September 13, 2021, starting at 7:00 AM Eastern Time.

Who is presenting for Histogen at the conference?

Richard W. Pascoe, the President and CEO of Histogen, will be the presenter.

What is Histogen Inc.'s focus in therapeutics?

Histogen focuses on developing restorative therapeutics that activate the body's natural repair processes.

What type of technologies does Histogen use?

Histogen utilizes cell-conditioned media and extracellular matrix materials from hypoxia-induced multipotent cells.

What are some therapeutic indications for Histogen's products?

Histogen's products target conditions such as joint cartilage regeneration and soft tissue repair.